Diagnostic accuracy of FibroScan-AST score in nonalcoholic steatohepatitis with significant activity and fibrosis

Gangde ZHAO; Simin GUO; Qing XIE; Honglian GUI

doi:10.3969/j.issn.1001-5256.2022.06.014

Volume 38 Issue 6

Jun. 2022

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2022 > 38(6): 1288-1292

PDF( 1857 KB)

Diagnostic accuracy of FibroScan-AST score in nonalcoholic steatohepatitis with significant activity and fibrosis

DOI: 10.3969/j.issn.1001-5256.2022.06.014

Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

More Information

Corresponding author: GUI Honglian, ghl11535@rjh.com.cn (ORCID:0000-0003-3624-4800)
Received Date: 2021-10-27
Accepted Date: 2021-11-29
Published Date: 2022-06-20

Abstract

Abstract

Objective To investigate the diagnostic accuracy of FibroScan-AST (FAST) score in patients with high-risk nonalcoholic steatohepatitis (NASH) with a nonalcoholic fatty liver disease (NAFLD) activity score of ≥4 and significant liver fibrosis (F ≥2), along with comparison with other serological models. Methods A total of 84 consecutively admitted patients hospitalized in Ruijin Hospital from January 2015 to December 2020 and biopsy-confirmed NAFLD/NASH were included in this study, and FibroScan (liver stiffness measurement and controlled attenuation parameter) and blood biochemical tests were performed at one week before and after liver biopsy. A Kruskal-Wallis H analysis of variance was used for comparison between multiple groups, and Spearman's correlation coefficient was used to analyze the correlation between variables. The receiver operating characteristic (ROC) curve was plotted with pathological results as the "gold standard", and the area under the ROC curve (AUC) was calculated. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and classification accuracy were calculated based on the cut-off values determined by previous studies. In subgroup analysis, the patients were divided into subgroups based on different clinical indices to evaluate the diagnostic accuracy of each model, which was expressed as AUC (95% confidence interval [CI]). Results Among the 84 patients, 43 had high-risk NASH. The FAST score was 0.54(0.04-0.93) for all patients, and the FAST score for liver fibrosis stages F0-F4 was 0.26(0.06-0.73), 0.48(0.04-0.82), 0.61(0.13-0.75), 0.64(0.09-0.93), and 0.82(0.75-0.89), respectively, with a significant difference between stages (H=23.360, P < 0.001). FAST score was positively correlated with liver fibrosis stage (r=0.491, P < 0.001). NAFLD fibrosis score (NFS), fibrosis-4 (FIB-4), and aspartate aminotransferase-to-platelet ratio index were positively correlated with liver fibrosis stage (r=0.230, 0.346, and 0.281, all P < 0.05), with a weaker correlation than FAST score. FAST score had an AUC of 0.725 (95%CI: 0.617-0.834, P < 0.001) in evaluating high-risk NASH. According to the low cut-off value determined by previous studies, FAST score ≤0.35 excluded high-risk NASH in 21 patients (25%) with an NPV of 71%; according to the high cut-off value, FAST score ≥0.67 helped to make a confirmed diagnosis of high-risk NASH in 19 patients (22.6%) with a PPV of 74%. NFS and FIB-4 had an AUC of 0.633(95%CI: 0.513-0.753) and 0.686(95%CI: 0.570-0.803), respectively, in the diagnosis of high-risk NASH (P < 0.05). Conclusion FAST score can accurately determine the presence or absence of high-risk NASH in NAFLD patients with or without metabolic risk factors, and selection of appropriate cut-off values can help some patients avoid liver biopsy.
- Non-alcoholic Fatty Liver Disease,
- Liver Cirrhosis,
- Elasticity Imaging Techniques,
- Biopsy

FullText(HTML)

References(11)

References

[1]	ZHOU F, ZHOU J, WANG W, et al. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: A systematic review and meta-analysis[J]. Hepatology, 2019, 70(4): 1119-1133. DOI: 10.1002/hep.30702.
[2]	KLEINER DE, BRUNT EM, WILSON LA, et al. Association of histologic disease activity with progression of nonalcoholic fatty liver disease[J]. JAMA Netw Open, 2019, 2(10): e1912565. DOI: 10.1001/jamanetworkopen.2019.12565.
[3]	NEWSOME PN, SASSO M, DEEKS JJ, et al. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: A prospective derivation and global validation study[J]. Lancet Gastroenterol Hepatol, 2020, 5(4): 362-373. DOI: 10.1016/S2468-1253(19)30383-8.
[4]	ANSTEE QM, LAWITZ EJ, ALKHOURI N, et al. Noninvasive tests accurately identify advanced fibrosis due to NASH: Baseline data from the STELLAR trials[J]. Hepatology, 2019, 70(5): 1521-1530. DOI: 10.1002/hep.30842.
[5]	SIDDIQUI MS, YAMADA G, VUPPALANCHI R, et al. Diagnostic accuracy of noninvasive fibrosis models to detect change in fibrosis stage[J]. Clin Gastroenterol Hepatol, 2019, 17(9): 1877-1885. e5. DOI: 10.1016/j.cgh.2018.12.031.
[6]	KLEINER DE, BRUNT EM, van NATTA M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease[J]. Hepatology, 2005, 41(6): 1313-1321. DOI: 10.1002/hep.20701.
[7]	HARRISON SA, RATZIU V, BOURSIER J, et al. A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: A prospective derivation and global validation study[J]. Lancet Gastroenterol Hepatol, 2020, 5(11): 970-985. DOI: 10.1016/S2468-1253(20)30252-1.
[8]	EDDOWES PJ, SASSO M, ALLISON M, et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease[J]. Gastroenterology, 2019, 156(6): 1717-1730. DOI: 10.1053/j.gastro.2019.01.042.
[9]	OEDA S, TAKAHASHI H, IMAJO K, et al. Diagnostic accuracy of FibroScan-AST score to identify non-alcoholic steatohepatitis with significant activity and fibrosis in Japanese patients with non-alcoholic fatty liver disease: Comparison between M and XL probes[J]. Hepatol Res, 2020, 50(7): 831-839. DOI: 10.1111/hepr.13508.
[10]	POYNARD T, MUNTENAU M, MORRA R, et al. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: A 2008 update[J]. Gastroenterol Clin Biol, 2008, 32(6 Suppl 1): 8-21. DOI: 10.1016/S0399-8320(08)73990-3.
[11]	BRIL F, MCPHAUL MJ, CAULFIELD MP, et al. Performance of plasma biomarkers and diagnostic panels for nonalcoholic steatohepatitis and advanced fibrosis in patients with type 2 diabetes[J]. Diabetes Care, 2020, 43(2): 290-297. DOI: 10.2337/dc19-1071.

Relative Articles

[1]	Meng LU, Mingjie WANG, Li CHEN. Advances in the application of elastography in noninvasive diagnosis of liver fibrosis in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2023, 39(2): 408-412. doi: 10.3969/j.issn.1001-5256.2023.02.025
[2]	Zhiran YANG, Linheng WANG, Yuan LI, Fusheng LIU, Yu WANG, Jianfang WANG, Runhua CHEN. Diagnostic value of transient elastography in the staging of hepatic fibrosis in patients with autoimmune liver disease: A Meta-analysis[J]. Journal of Clinical Hepatology, 2022, 38(1): 97-103. doi: 10.3969/j.issn.1001-5256.2022.01.015
[3]	Jianpeng LIU, Zhongjie YU, Hanxiao WANG, Wenxia ZHAO. Performance of controlled attenuation parameter measured by FibroScan in the diagnosis of nonalcoholic fatty liver disease and its association with traditional Chinese medicine syndrome types[J]. Journal of Clinical Hepatology, 2021, 37(12): 2869-2873. doi: 10.3969/j.issn.1001-5256.2021.12.026
[4]	Kaimin SONG, Jun LIU. Advances in the application of transient elastography in chronic hepatitis B[J]. Journal of Clinical Hepatology, 2021, 37(2): 419-424. doi: 10.3969/j.issn.1001-5256.2021.02.036
[5]	Mingjie YAO, Xiajie WEN, Leijie WANG, Qiong HE, Jianwen LUO, Jiangao FAN, Qing XIE, Chengwei CHEN, Qing Chun FU, Jun Ping SHI, Yongfeng YANG, Yun XU, Lungen LU, Fengmin LU. Establishment of a model for evaluating the severity of nonalcoholic fatty liver disease based on transient elastography parameters[J]. Journal of Clinical Hepatology, 2021, 37(7): 1614-1618. doi: 10.3969/j.issn.1001-5256.2021.07.027
[6]	Chen WeiTing, Li ShuangJie. Clinical value of transient elastography,aspartate aminotransferase-to-platelet ratio index,and fibrosis-4 in the diagnosis of liver fibrosis in children with biliary atresia[J]. Journal of Clinical Hepatology, 2020, 36(3): 546-550. doi: 10.3969/j.issn.1001-5256.2020.03.015
[7]	SUN YiFei, HUANG LiPing. Noninvasive evaluation of esophageal and gastric varices in liver cirrhosis by shear-wave ultrasound elastography[J]. Journal of Clinical Hepatology, 2020, 36(12): 2815-2818. doi: 10.3969/j.issn.1001-5256.2020.12.036
[8]	Zhang DaKun, Chen Min, Zhang WenHui, Wang RuiFang, Shi XiaoJuan. Clinical value of acoustic radiation force impulse elastography in predicting esophageal variceal bleeding in liver cirrhosis[J]. Journal of Clinical Hepatology, 2020, 36(3): 561-564. doi: 10.3969/j.issn.1001-5256.2020.03.018
[9]	Liu LinXiang, Nie Yuan, Zhu Xuan. Clinical application of transient elastography in liver cirrhosis and its complications[J]. Journal of Clinical Hepatology, 2020, 36(6): 1362-1365. doi: 10.3969/j.issn.1001-5256.2020.06.037
[10]	Wang XiaoXiao, Zhao Jie, Li XiaoHe, Rao HuiYing, Wei Lai, Liu Feng. Value of second harmonic generation/two-photon excitation fluorescence in quantitative evaluation of liver fibrosis in mice with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2019, 35(8): 1786-1790. doi: 10.3969/j.issn.1001-5256.2019.08.027
[11]	Jiao DeChao, Lei QinYu, Han XinWei, Li ZongMing, Bi YongHua, Zhang QuanHui. Clinical value of ultra-thin electronic flexible endoscopy combined with intraluminal ultrasound in assisting percutaneous transhepatic biliary stricture biopsy[J]. Journal of Clinical Hepatology, 2019, 35(12): 2744-2747. doi: 10.3969/j.issn.1001-5256.2019.12.021
[12]	Xu FengMing, Sheng QingShou. Research advances in serum markers and transient elastography in the evaluation of liver fibrosis[J]. Journal of Clinical Hepatology, 2018, 34(3): 618-622. doi: 10.3969/j.issn.1001-5256.2018.03.040
[13]	Dong Xue, Huang LiPing. Research advances in the value of ultrasound elastography in the diagnosis of gastroesophageal varices in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2018, 34(11): 2424-2427. doi: 10.3969/j.issn.1001-5256.2018.11.035
[14]	Wu DongBo, Chen EnQiang, Bai Lang, Tang Hong. Liver biopsy and related techniques in pathological diagnosis[J]. Journal of Clinical Hepatology, 2018, 34(11): 2295-2299. doi: 10.3969/j.issn.1001-5256.2018.11.006
[15]	Wang Yan, Hou JinLin. Hepatic fibrosis in nonalcoholic fatty liver disease and its quantitative assessment[J]. Journal of Clinical Hepatology, 2017, 33(12): 2296-2302. doi: 10.3969/j.issn.1001-5256.2017.12.008
[16]	Lin XiaoLing, Deng ChaoWen, Hu GuoXin. An excerpt of American gastroenterological association institute guideline on the role of elastography in the evaluation of liver fibrosis(2017)[J]. Journal of Clinical Hepatology, 2017, 33(10): 1895-1897. doi: 10.3969/j.issn.1001-5256.2017.10.009
[17]	Zhuang XiaoFang, Sun Jie, Wang XiaoBo, Wang Yan, Wu QiQi, Wang XiaoZhong. Performance of transient elastography in diagnosis of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(12): 2366-2371. doi: 10.3969/j.issn.1001-5256.2017.12.022
[18]	Shi MeiJie, Zhang ChaoZhen, Chi XiaoLing, Xie YuBao, Xiao HuanMing. Analysis of clinical high-risk factors for hepatitis B cirrhosis confirmed by liver biopsy[J]. Journal of Clinical Hepatology, 2014, 30(2): 149-152. doi: 10.3969/j.issn.1001-5256.2014.02.013
[19]	Zhang GuoSheng, Wang TianYi, Xu YouQing, Zhou Li, Geng Nan, Chen Yu. Diagnostic value of real-time tissue elastography for liver fibrosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2014, 30(7): 616-619. doi: 10.3969/j.issn.1001-5256.2014.07.010
[20]	Mai Jing, Gao YueQiu. The application of magnetic resonace elastography in the non-invasive diagnosis of hepatic fibrosis[J]. Journal of Clinical Hepatology, 2011, 27(3): 318-320+324.

Supplements(0)

Cited By

Cited by

Periodical cited type(3)

1.	吴韵怡，敬强安，杜璟，童向民. 基于铁蛋白等血清学指标的早期NAFLD诊断模型的建立与验证. 中国现代医生. 2024(06): 36-39 .
2.	葛启超，陆伦根. 肝活检在非酒精性脂肪性肝病诊断和临床试验中的价值. 临床肝胆病杂志. 2024(11): 2288-2292 . 本站查看
3.	曾箭云，刘艳华，钟志民，钟启盛. 肝脏组织硬度与慢性乙型肝炎患者肝组织纤维化的相关性研究及诊断效能分析. 中国当代医药. 2023(35): 49-52+56 .

Other cited types(3)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Tables(3)

Get Citation

PDF

XML

Article Metrics

Article views (1241) PDF downloads(136)

Diagnostic accuracy of FibroScan-AST score in nonalcoholic steatohepatitis with significant activity and fibrosis

DOI: 10.3969/j.issn.1001-5256.2022.06.014